Cited by 3,655Lung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Diagnosis and Treatment

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

Open access
Goldstraw, Peter, Crowley, John, Chansky, Kari, Giroux, Dorothy J., Groome, Patti A., Rami-Porta, Ramon, Postmus, Pieter E., Rusch, Valerie +1 more·2007·Journal of Thoracic Oncology

Abstract

Introduction The seventh edition of the TNM Classification of Malignant Tumors is due to be published early in 2009. In preparation for this, the International Association for the Study of Lung Cancer established its Lung Cancer Staging Project in 1998. The recommendations of this committee for changes to the T, N, and M descriptors have been published. This report contains the proposals for the new stage groupings.Methods Data were contributed from 46 sources in more than 19 countries. Adequate data were available on 67,725 cases of non-small cell lung cancer treated by all modalities of care between 1990 and 2000. The recommendations for changes to the T, N, and M descriptors were incorporated into TNM subsets. Candidate stage groupings were developed on a training subset and tested in a validation subset.Results The suggestions include additional cutoffs for tumor size, with tumors >7 cm moving from T2 to T3; reassigning the category given to additional pulmonary nodules in some locations; and reclassifying pleural effusion as an M descriptor. In addition, it is suggested that T2b N0 M0 cases be moved from stage IB to stage IIA, T2a N1 M0 cases from stage IIB to stage IIA, and T4 N0-1 M0 cases from stage IIIB to stage IIIA.Conclusions Such changes, if accepted, will involve a reassessment of existing treatment algorithms. However, they are based on an intensive and validated analysis of the largest database to date. The proposed changes would improve the alignment of TNM stage with prognosis and, in certain subsets, with treatment.

Integrity signals

Registry

Crossref · 10.1097/jto.0b013e31812f3c1a

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Following the AJCC guideline, individual pathologic T, N, and M stage components can be summarized into an overall pathologic staging score of Stage I, II, III, or IV.

    “Following the AJCC guideline, individual pathologic T, N, and M stage components can be summarized into an overall pathologic staging score of Stage I, II, III, or IV.”

The citation lists haven’t been fetched yet

References 24 · Cited by 3,655

Authors
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L.
Affiliations
  • Royal Brompton Hospital (GB)
  • Cancer Research And Biostatistics (US)
  • Vrije Universiteit Amsterdam (NL)
  • Memorial Sloan Kettering Cancer Center (US)
  • Armed Forces Institute of Pathology (US)
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2007-08
Volume
2
Issue
8
Pages
706-714
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2088720324
Cited by
3,655
References
24
Citations by year
2026: 25 · 2025: 52 · 2024: 78 · 2023: 87 · 2022: 112 · 2021: 132 · 2020: 200 · 2019: 204 · 2018: 267 · 2017: 296 · 2016: 291 · 2015: 364 · 2014: 306 · 2013: 306 · 2012: 258
FWCI
128.66
Type
journal article
Language
en
Open access
Locations
  • Journal of Thoracic Oncology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
  • Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
Keywords
non-small cell lung cancer, TNM staging, lung cancer staging, tumor size classification, pulmonary nodules, pleural effusion, treatment algorithm
MeSH terms
Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Neoplasm Staging, Prognosis, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review